cost of diagnosing bladder cancer
common cancer
type of cancer
management of bladder cancer patients
BLACANDI system
solution BLACANDI
BLACANDI project
cost of diagnosis
selected biomarkers
routine cystoscopy
patented filtration device
new combination of biomarkers
large clinical validation
technology
inexpensive test
urine
year
half
different health care systems
recurrence routine tests
small clinical trial
new cases
expensive procedures
highest lifetime treatment costs
customization
enormous burden
absence
Denmark
Danish SME Genomic Expression Aps
relapsing nature
selection of tumor cells
operational solutions
Current diagnostics
hematuria
life quality
Europe
feasibility study
business strategy
blood
maturation
high incidence
phase
opportunity
need
cancers
Preliminary results